PREVALENCE OF VITAMIN D DEFICIENCY AMONG THE PATIENTS PRESENTING WITH CHRONIC FATIGUE, 2025, Arshad

Dolphin

Senior Member (Voting Rights)
[On a quick skim, it's not clear that these people definitely had CFS]


PDF: https://fmhr.org/index.php/fmhr/article/view/694/625

Vol. 3 No. 5 (2025)

PREVALENCE OF VITAMIN D DEFICIENCY AMONG THE PATIENTS PRESENTING WITH CHRONIC FATIGUE​

Articles
Published 2025-07-31
  • Dr. Nabila Arshad
  • Dr Shahid Nawaz
  • Dr. Sadaf Arshad
  • Dr. Muniba Arshad
  • Dr. Aymen Jabbar


Keywords​

Vitamin D deficiency
chronic fatigue syndrome

How to Cite​

PREVALENCE OF VITAMIN D DEFICIENCY AMONG THE PATIENTS PRESENTING WITH CHRONIC FATIGUE. (2025). Frontier in Medical and Health Research, 3(5), 1493-1496. https://fmhr.org/index.php/fmhr/article/view/694

Abstract​

Objective:

To determine prevalence of Vitamin D deficiency among patients presenting with chronic fatigue syndrome (CFS).

Methods:

This study employed a cross-sectional design, involving 138 participants aged between 18 and 65 years, inclusive of all genders. All participants had a confirmed diagnosis of CFS persisting for at least four weeks. A sample of three milliliters of blood was collected from each participant for vitamin D testing. Individuals were classified as vitamin D deficient if their blood vitamin D concentration was below 20 nanograms per milliliter.

Results:

The mean age of patients was 39.5±11.9 years. The mean duration of their illness was 3.4 ± 1.3 months. Male participants numbered 117, comprising about 69.6% of the total patients. Out of 168 patients, 124 (73.81%) had vitamin D deficiency.

Conclusion:

There is a high prevalence of vitamin D deficiency in patients presenting with CFS. Therefore, vitamin D screening should be conducted in all patients with CFS.
 
All participants had a confirmed diagnosis of CFS persisting for at least four weeks.

Their defining reference is Updated NICE guidance on chronic fatigue syndrome (2020, Turner-Stokes and Wade) !!

70% male. Duration of illness 3.4 ± 1.3 months.

The results are presented as "Vitamin D Yes/No" (they mean deficiency, defined as <20 ng/mL).

The study did not account for seasonal fluctuations that affect vitamin D production and dietary consumption, nor did it assess other influencing factors such as serum calcium levels, parathyroid hormone levels, or thyroid function. Despite these constraints, the results offer meaningful insights into the potential advantages of early identification and treatment of vitamin D deficiency in individuals with CFS.

Irrelevant to ME/CFS. And the shouty title is just annoying.
 
Last edited:
Back
Top Bottom